(Q38005743)

26 August 2017

The immunosuppressive molecule HLA-G and its clinical implications (English)

1 reference

26 August 2017

2

1 reference

26 August 2017

5

Edgardo D Carosella

1 reference

26 August 2017

Alvaro González

1

1 reference

26 August 2017

Joel LeMaoult

series ordinal

3

1 reference

26 August 2017

Peter A Horn

series ordinal

4

1 reference

26 August 2017

Estibaliz Alegre

series ordinal

6

1 reference

26 August 2017

26 April 2012

1 reference

Critical Reviews in Clinical Laboratory Sciences

26 August 2017

1 reference

26 August 2017

49

1 reference

26 August 2017

3

1 reference

26 August 2017

63-84

1 reference

A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A class I antigen, HLA-G, expressed in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Tolerization of dendritic cells by HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Lack of Histocompatibility Leukocyte Antigen-G expression in early embryos is not related to germinal defects or impairment of interleukin-10 production by embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G in organ transplantation: towards clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Modulation of HLA-G expression in human neural cells after neurotropic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Disulfide bond-mediated dimerization of HLA-G on the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G*0105N null allele encodes functional HLA-G isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Identification of six new HLA-G alleles with non-coding DNA base changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

RREB-1 is a transcriptional repressor of HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Progesterone regulates HLA-G gene expression through a novel progesterone response element

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Secretion of sHLA-G molecules in malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G gene repression is reversed by demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of HLA G in human tumors is not a frequent event.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression and regulation of non-classical HLA-G in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Allele-specific targeting of microRNAs to HLA-G and risk of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Detection of soluble HLA-G molecules in plasma and amniotic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Quantification and identification of soluble HLA-G isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Emerging topics and new perspectives on HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression during preimplantation human embryo development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression in human embryonic stem cells and preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The LILR family: modulators of innate and adaptive immune pathways in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G and control of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Allergic women have reduced sHLA-G plasma levels at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Variation in the HLA-G Promoter Region Influences Miscarriage Rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression is up-regulated by progesterone in mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompati

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G expression in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Trogocytosis-based generation of suppressive NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Membrane redistributions through multi-intercellular exchanges and serial trogocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Exosomes bearing HLA-G are released by melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.677947

10.3109/10408363.2012.677947

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference